Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Tax Provisions: 2021-2025

Historic Tax Provisions for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Sep 2025 value amounting to $8.7 million.

  • Kiniksa Pharmaceuticals International's Tax Provisions rose 58.81% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 million, marking a year-over-year increase of 265.93%. This contributed to the annual value of $7.0 million for FY2024, which is 122.91% up from last year.
  • As of Q3 2025, Kiniksa Pharmaceuticals International's Tax Provisions stood at $8.7 million, which was up 72.88% from $5.0 million recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Tax Provisions registered a high of $8.7 million during Q3 2025, and its lowest value of -$177.4 million during Q3 2022.
  • In the last 3 years, Kiniksa Pharmaceuticals International's Tax Provisions had a median value of $5.0 million in 2025 and averaged -$263,818.
  • The largest annual percentage gain for Kiniksa Pharmaceuticals International's Tax Provisions in the last 5 years was 816.67% (2022), contrasted with its biggest fall of 150,203.39% (2022).
  • Kiniksa Pharmaceuticals International's Tax Provisions (Quarterly) stood at $279,000 in 2021, then surged by 753.05% to $2.4 million in 2022, then plummeted by 1,057.44% to -$22.8 million in 2023, then surged by 64.49% to -$8.1 million in 2024, then surged by 58.81% to $8.7 million in 2025.
  • Its Tax Provisions was $8.7 million in Q3 2025, compared to $5.0 million in Q2 2025 and $7.0 million in Q1 2025.